Morpholino

MO2-agrn

ID
ZDB-MRPHLNO-070411-2
Name
MO2-agrn
Previous Names
  • zfAgrinLG2-MO (1)
Target
Sequence
5' - CCTCTCCTTTACGCTGTGAAGACAA - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-agrn
Expressed Gene Anatomy Figures
agrn Fig. 3 from Zhang et al., 2011
Fig. 3 from Kim et al., 2007
alcama Fig. 4 from Liu et al., 2008
atoh7 Fig. 5 from Liu et al., 2008
dmbx1a Fig. 5 from Zhang et al., 2011
Fig. 2 from Liu et al., 2008
efna5a Fig. 6 from Liu et al., 2008
efna5b Fig. 6 from Liu et al., 2008
egr2b Fig. 4 from Zhang et al., 2017
en2b Fig. 8 from Zhang et al., 2017
epha4a Fig. 3 from Zhang et al., 2017
etv4 Fig. 10 from Liu et al., 2008
fgf8a Fig. 6 from Zhang et al., 2017
Fig. 8 from Liu et al., 2008
gad1b Fig. S2 from Zhang et al., 2014
otx2b Fig. 1 from Zhang et al., 2017
pax2a Fig. 5 from Zhang et al., 2017
Fig. 5 from Liu et al., 2008
pax6a Fig. 2 from Zhang et al., 2017
Fig. S2 from Zhang et al., 2014
Fig. 4 from Zhang et al., 2011
Fig. 2 from Liu et al., 2008
wnt1 Fig. 7 from Zhang et al., 2017
Phenotype
Phenotype resulting from MO2-agrn
Phenotype Fish Figures
cranial nerve II decreased size, abnormal WT + MO2-agrn Fig. 4 from Liu et al., 2008
cranial nerve II axon decreased amount, abnormal s356tTg + MO2-agrn Fig. 6 from Liu et al., 2008
eye apoptotic, abnormal WT + MO2-agrn Fig. 3 from Liu et al., 2008
eye pax6a expression decreased amount, abnormal AB + MO2-agrn Fig. 2 from Zhang et al., 2017
eye dmbx1a expression decreased amount, abnormal AB + MO2-agrn Fig. 5 from Zhang et al., 2011
eye decreased diameter, abnormal AB + MO2-agrn Fig. 2 from Zhang et al., 2011
eye decreased size, abnormal AB + MO2-agrn Fig. 1 from Zhang et al., 2011
eye dmbx1a expression spatial pattern, abnormal AB + MO2-agrn Fig. 5 from Zhang et al., 2011
forebrain pax6a expression decreased amount, abnormal AB + MO2-agrn Fig. 2 from Zhang et al., 2017
hindbrain pax6a expression decreased amount, abnormal AB + MO2-agrn Fig. 2 from Zhang et al., 2017
hindbrain neuron decreased amount, abnormal knu3Tg + MO2-agrn Fig. 9 from Kim et al., 2007
neuron differentiation disrupted, abnormal knu3Tg + MO2-agrn Fig. 9 from Kim et al., 2007
retina pax6a expression decreased amount, abnormal AB + MO2-agrn Fig. 4 from Zhang et al., 2011
retina layer formation disrupted, abnormal AB + MO2-agrn Fig. 1 from Zhang et al., 2011
retinal ganglion cell layer apoptotic, abnormal WT + MO2-agrn Fig. 3 from Liu et al., 2008
retinal ganglion cell layer agrn expression decreased amount, abnormal AB + MO2-agrn Fig. 3 from Zhang et al., 2011
retinal ganglion cell layer decreased size, abnormal knu3Tg + MO2-agrn Fig. 4 from Liu et al., 2008
retinal ganglion cell layer neuron projection mislocalised, abnormal WT + MO2-agrn Fig. 6 from Liu et al., 2008
retinal inner nuclear layer agrn expression decreased amount, abnormal AB + MO2-agrn Fig. 3 from Zhang et al., 2011
spinal cord neuron decreased amount, abnormal knu3Tg + MO2-agrn Fig. 9 from Kim et al., 2007
Phenotype of all Fish created by or utilizing MO2-agrn
Phenotype Fish Conditions Figures
eye decreased diameter, abnormal AB + MO2-agrn standard conditions Fig. 2 from Zhang et al., 2011
eye dmbx1a expression spatial pattern, abnormal AB + MO2-agrn standard conditions Fig. 5 from Zhang et al., 2011
eye decreased size, abnormal AB + MO2-agrn chemical treatment by environment: ethanol Fig. 3 from Zhang et al., 2011
brain hypoplastic, abnormal AB + MO2-agrn chemical treatment by environment: ethanol Fig. 3 from Zhang et al., 2011
forebrain pax6a expression decreased amount, abnormal AB + MO2-agrn standard conditions Fig. 2 from Zhang et al., 2017
hindbrain pax6a expression decreased amount, abnormal AB + MO2-agrn standard conditions Fig. 2 from Zhang et al., 2017
eye dmbx1a expression decreased amount, abnormal AB + MO2-agrn chemical treatment by environment: ethanol Fig. 5 from Zhang et al., 2011
retinal inner nuclear layer agrn expression decreased amount, abnormal AB + MO2-agrn chemical treatment by environment: ethanol Fig. 3 from Zhang et al., 2011
retinal inner nuclear layer agrn expression decreased amount, abnormal AB + MO2-agrn standard conditions Fig. 3 from Zhang et al., 2011
eye dmbx1a expression decreased amount, abnormal AB + MO2-agrn standard conditions Fig. 5 from Zhang et al., 2011
retina pax6a expression decreased amount, abnormal AB + MO2-agrn chemical treatment by environment: ethanol Fig. 4 from Zhang et al., 2011
retinal ganglion cell layer agrn expression decreased amount, abnormal AB + MO2-agrn standard conditions Fig. 3 from Zhang et al., 2011
retina layer formation disrupted, abnormal AB + MO2-agrn standard conditions Fig. 1 from Zhang et al., 2011
eye dmbx1a expression spatial pattern, abnormal AB + MO2-agrn chemical treatment by environment: ethanol Fig. 5 from Zhang et al., 2011
eye decreased size, abnormal AB + MO2-agrn standard conditions Fig. 1 from Zhang et al., 2011
retinal ganglion cell layer agrn expression decreased amount, abnormal AB + MO2-agrn chemical treatment by environment: ethanol Fig. 3 from Zhang et al., 2011
eye pax6a expression decreased amount, abnormal AB + MO2-agrn standard conditions Fig. 2 from Zhang et al., 2017
retina pax6a expression decreased amount, abnormal AB + MO2-agrn standard conditions Fig. 4 from Zhang et al., 2011
eye decreased size, abnormal WT + MO2-agrn chemical treatment: ethanol Fig. S1 from Zhang et al., 2014
retinal ganglion cell layer neuron projection mislocalised, abnormal WT + MO2-agrn standard conditions Fig. 6 from Liu et al., 2008
retinal ganglion cell layer decreased size, abnormal WT + MO2-agrn standard conditions Fig. 4 from Liu et al., 2008
cranial nerve II decreased size, abnormal WT + MO2-agrn standard conditions Fig. 4 from Liu et al., 2008
midbrain-hindbrain boundary development process quality, abnormal WT + MO2-agrn chemical treatment: ethanol Fig. 10,  Fig. S1 from Zhang et al., 2014
retinal ganglion cell layer apoptotic, abnormal WT + MO2-agrn standard conditions Fig. 3 from Liu et al., 2008
eye apoptotic, abnormal WT + MO2-agrn standard conditions Fig. 3 from Liu et al., 2008
retinal ganglion cell layer decreased size, abnormal knu3Tg + MO2-agrn standard conditions Fig. 4 from Liu et al., 2008
neuron differentiation disrupted, abnormal knu3Tg + MO2-agrn standard conditions Fig. 9 from Kim et al., 2007
spinal cord neuron decreased amount, abnormal knu3Tg + MO2-agrn standard conditions Fig. 9 from Kim et al., 2007
hindbrain neuron decreased amount, abnormal knu3Tg + MO2-agrn standard conditions Fig. 9 from Kim et al., 2007
cranial nerve II axon decreased amount, abnormal s356tTg + MO2-agrn standard conditions Fig. 6 from Liu et al., 2008
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.